Bristol-Myers Squibb Company (NYSE:BMY) is included in our list of the 12 deep value stocks to invest in. On November 3, 2025 ...
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best undervalued stocks to buy under $50. Bristol-Myers Squibb Company ...
Bristol-Myers Squibb (NYSE: BMY) has considerably lagged behind the overall market, with its stock decreasing by 20% this year, while the S&P 500 index has risen by 14%. This drop can be attributed in ...
Bristol-Myers Squibb Company remains a solid, cash-generative blue-chip stock, with expected slow growth & patience. Learn more about BMY stock here.
15don MSN
Bristol-Myers Squibb Q3 Earnings Preview: Pharma giant looks to reinvent growth amid patent pressure
Bristol-Myers Squibb Company (NYSE: BMY) is set to report its third-quarter 2025 earnings on Thursday, October 30, before the market opens. Wall Street expects earnings per share of $1.52, down 15.6% ...
Bristol-Myers Squibb Company (($BMY)) has held its Q3 earnings call. Read on for the main highlights of the call.
InvestorsHub on MSN
Bristol-Myers Squibb lifts annual outlook after topping Q3 forecasts
Bristol-Myers Squibb (NYSE:BMY) raised its full-year outlook on Thursday after delivering third-quarter results that exceeded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback